The Saudi Society of Clinical Pharmacy and AstraZeneca establish a first-of-its-kind Saudi Oncology Health Economics Expert Group
SHARP aims to create a database evaluating cancer treatments
Press Release - Friday 13 December 2019
Ibnsina Pharma S.A.E. (ISPH.CA)
Also known as: ISP, Ibnsina
9.07 EGP -0.14-1.52%
ISP Stock Price & Performance
Recommendation
-
Div Yield
-
P/E (Last 12 Month)
0.0
Upside
-
Target Price (Mean)
-
Open
9.10 EGP
Previous Close
9.21 EGP
Turnover
390.49K EGP
EPS
0.39 EGP
Volume
42,627
Transactions
14
Market Cap
7.55B EGP
IPO Date
08-Nov-2017
Analyst Estimates
| EPS | Revenue | |
|---|---|---|
| Mean Estimate |  | |
| Smart Estimate | | |
| Predicted Surprise | | |
| Mean Chg % | | |
Starmine Models
StarMine provides a suite of proprietary alpha-generating analytics and models spanning sectors, regions, and markets.
| Bullish | |
|---|---|
| Value Momentum | |
| Intrinsic Valuation | |
| Relative Valuation | |
| Credit Risk - Smart Ratios | |
| Credit Risk- Text Mining | |
| Bearish | |
|---|---|
| Price Momentum | |
About Ibnsina Pharma S.A.E.
Business Summary
Distribution of pharmaceuticals, veterinary products, cosmetics, food supplements, pesticides, medical supplies and equipment.
Country of Incorporation
Ownership Type
Established In
2002
Primary Sector
Number of Employees
5667
Stock Listing
| ID | Stock Type | Currency | Exchange | Symbol |
|---|---|---|---|---|
| ISPH.CASE | Ordinary | EGP | Egypt SE | ISPH |
Contact details
Primary address
Ibnsina Pharma S.A.E. BuildingIndustrial Zone 1, Plot 2-3, Block 12-15
91
Egypt
Oubour
CONTACT
- Tel: +202 2-4489-1102
- Tel: +202 2-4489-1103
- Fax: +202 2-4489-1137
- Email: www.ibnsina-pharma.com
Related links
www.ebrd.comRegion
QalyubiaOwnership
Ownership
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Holding Concentrations
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Financials
Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing
Executives
Mr Omar Mohammed Abdel-Gawad Mahmoud
Co-Chief Executive Officer
Mr Mahmoud Mohammed Abdel-Gawad Mahmoud
Co-Chief Executive Officer
Mr Momen Gomaa
Chief Financial Officer
Board Members
Mr Mohammed Mohsen Mohammed Mahgoub
Chairman
Mr Abdulrahim Fahmi Omar
Director representing Faisal Islamic Bank of Egypt
Mr Lindsay Movar Forbes
Director representing European Bank for Reconstruction and Development
Company information provided by © 2019 Thomson Reuters
Thomson Reuters research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).
Morning Briefing
Thursday Outlook: Investors on edge as tariffs, UK election, ECB loom
Oil prices edge higher as OPEC revises forecast; Aramco flotation propels Saudi bourse into global top ten
Read MoreStock Market Data
Powered By Knowledge Direct